EDGAR Filing Documents for 0001213900-21-015453

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-21-015453

Filing Date

2021-03-16

Accepted

2021-03-15 18:53:38

Documents

107

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f20f2020_purplebiotech.htm	20-F	2859510
2	DESCRIPTION OF SHARE CAPITAL	f20f2020ex2-1_purplebiotech.htm	EX-2.1	140043
3	PURPLE BIOTECH LTD. 2016 EQUITY-BASED INCENTIVE PLAN, AS AMENDED	f20f2020ex4-3_purplebiotech.htm	EX-4.3	141646
4	FIRST AMENDMENT TO PRODUCT MANUFACTURING AGREEMENT, EFFECTIVE AS OF MAY 17, 2020	f20f2020ex4-29_purplebiotech.htm	EX-4.29	66062
5	CERTIFICATION	f20f2020ex12-1_purplebiotech.htm	EX-12.1	14750
6	CERTIFICATION	f20f2020ex12-2_purplebiotech.htm	EX-12.2	14102
7	CERTIFICATION	f20f2020ex13-1_purplebiotech.htm	EX-13.1	6477
8	CERTIFICATION	f20f2020ex13-2_purplebiotech.htm	EX-13.2	6409
9	CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB	f20f2020ex15-1_purplebiotech.htm	EX-15.1	4319
10	GRAPHIC	img_001.jpg	GRAPHIC	17259
11	GRAPHIC	img_002.jpg	GRAPHIC	31866
12	GRAPHIC	img_003.jpg	GRAPHIC	12894
	Complete submission text file	0001213900-21-015453.txt		8686574

Data Files

Seq	Description	Document	Type	Size
13	XBRL INSTANCE FILE	ppbt-20201231.xml	EX-101.INS	1409309
14	XBRL SCHEMA FILE	ppbt-20201231.xsd	EX-101.SCH	106786
15	XBRL CALCULATION FILE	ppbt-20201231_cal.xml	EX-101.CAL	75321
16	XBRL DEFINITION FILE	ppbt-20201231_def.xml	EX-101.DEF	247999
17	XBRL LABEL FILE	ppbt-20201231_lab.xml	EX-101.LAB	497693
18	XBRL PRESENTATION FILE	ppbt-20201231_pre.xml	EX-101.PRE	370455

Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104

Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121

PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)